We've presented just a brief overview of findings from the recent GALLIUM study and related online sources.
There are many intricacies in the treatment protocol to be considered, along with some ambiguities regarding research findings.
The best source of information regarding treatment regimens is, as always, your oncologist and healthcare team.
When speaking with them, be sure to ask any questions you may have.
Freely discuss the ‘risks vs. benefits’ regarding bendamustine.
Make sure you understand the options open to you, as your oncologist and you, together, choose the treatment modality that best fits your treatment needs.